Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

On June 1, 2021, the Governor of Louisiana signed legislation that banned “white bagging” in the state, ensuring that health insurers cannot refuse to pay for approved physician-administered drugs and related services to covered patients. It is the first such law in the United States.
Before the COVID-19 pandemic, patients with cancer received care in three settings: hospital inpatient, hospital emergency room, and the outpatient clinic. But just as the pandemic overturned deep-rooted barriers to telehealth uptake, it also brought renewed attention to the hospital-at-home model.
ACCC was one of 336 organizations that signed onto a letter to Congress on January 31, 2022, in support of comprehensive telehealth reform. The recommendations aim to provide significant relief to patients and providers concerned about the commitment to telehealth after the end of the COVID-19 public health emergency.
Led by the Prevent Cancer Foundation, ACCC has joined more than 300 organizations in signing a letter urging the passage of the MCED Screening Coverage Act, which will help cancer care providers be able to use the latest testing technologies to improve quality of life and better patient outcomes.
In a letter to Senate Health, Education, Labor & Pensions (HELP) Committee leadership, ACCC and 71 other patient advocacy organizations urge the Committee to include House-passed clinical trials diversity provisions in the Senate version of the Prescription Drug User Fee Act (PDUFA) reauthorization package. Read the Letter
The ACCC Community Oncology Research Institute (ACORI) Task Force submitted comments to the Food and Drug Administration (FDA) in response to the agency's draft guidance on Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials. Read the Letter
ACCC convened its members, sponsors, and industry partners in person (for the first time since the dawn of the COVID-19 pandemic) and online for the 48th Annual Meeting and Cancer Center Business Summit in Washington, D.C., enabling more people to participate in ways in which they were most comfortable.
With the COVID-19 pandemic resulting in unprecedented unemployment and an economic recession, financial advocacy services for cancer patients are more important than ever. At any given time, the job of financial advocates and navigators requires them to stay on top of rapidly changing assistance programs, insurance coverage changes, new state healthcare laws, and evolving community resources. The pandemic …
ACCC wrote a letter to Senate Finance Committee Chairman Ron Wyden and Ranking Member Mike Crapo regarding drug pricing legislation being worked on by members of Congress. The letter asks that Congress remove providers from the middle of proposed drug pricing negotiations between the federal government and drug manufactures, siting the potential for negative repercussions on cancer care providers and …
ACCC joined more than 400 organization from all 50 states to urge Congress to pass the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R.1946/S.1873) this year. This legislation would create a pathway for MCED tests to be covered by the Medicare program following approval by the Food and Drug Administration (FDA). Read the Letter
Accurate and timely staging is critical in determining the appropriate approach to treatment for gastric cancer.
FDA Approves ELZONRISTM (tagraxofusp), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy Stemline Therapeutics Inc Logo FDA Approves ELZONRISTM (tagraxofusp), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy December 21, 2018 ELZONRIS is approved to treat adult and pediatric patients …
Caring for cancer patients can be a drain—physically, intellectually, and emotionally—for each member of the multidisciplinary cancer care team, starting with the receptionist who greets the patients daily to the physician in whose hands patients place their total trust.
The Swedish Cancer Institute (SCI) has a long history of providing the nurturing care of a community-based hospital while giving patients access to the latest cancer therapies. In 2013 we took on the question of how to integrate personalized, genomic medicine into our program.
DRAFT BMY Patient Support Initiative Release (01186912.DOCX;16) Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S. Immediate Relief Available PRINCETON, N.J. – April 7, 2020 – Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient support programs to help eligible unemployed patients …
This article describes molecular subtyping and shows how it is changing both the understanding of breast cancer and how to treat it. The article summarizes the most important new studies and details the impact of this new information for community cancer centers.
Telehealth can improve the experience of patients with cancer by facilitating access and reducing cost.
PowerPoint Presentation Authors: Joseph Kim1, Elana Plotkin2, Leigh Boehmer2, Timothy Craig Allen3, Pablo Gutman4, Michelle Shiller5, Sandra Brown6, Vivian Pan7 1Xaf Solutions, Newtown, PA; 2Association of Community Cancer Centers, Rockville, MD; 3University of Mississippi Medical Center, Jackson, MS; 4Holy Cross Health, Silver Spring, MD; 5Baylor Scott & White Health, Dallas, TX; 6Providence …
https://meetinglibrary.asco.org/record/187203/abstract 1/2 An optimal care coordination model for Medicaid patients with lung cancer: Lessons learned from the beta testing phase of a multisite initiative in the United States. Authors: Matthew Smeltzer, Leigh Boehmer, Amanda Kramar, Thomas Asfeldt, Nicholas Ryan Faris, Meredith Ray, Christopher S. Lathan, Raymond U. Osarogiagbon; University of …
Closing out 2017, uncertainty continues to cloud the healthcare reform picture.